Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.
Mainz Biomed Announces Stock Split – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 29.11.2024 / 14:45 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed